Novel CRISPRi Repressors Enhance Gene Regulation in Mammalian Cells

Strategic Insights -

Research conducted at the Georgia Institute of Technology has led to the development of novel CRISPRi repressors that can efficiently regulate gene expression in mammalian cells. The study aimed to address the existing limitations of CRISPRi, including incomplete knockdown, performance variability, and inconsistencies dependent on guide RNA sequences. By combining novel repressor domains with strong Kruppel-associated box (KRAB) repressors, the researchers created 100 bipartite and tripartite fusion proteins and screened them for their ability to reduce gene expression as CRISPRi effectors. The study identified a particularly effective CRISPRi platform, dCas9-ZIM3(KRAB)-MeCP2(t), which showed improved gene repression of endogenous targets across several cell lines and in genome-wide screens.

Key Takeaways:

  • The research developed novel CRISPRi repressors that can efficiently regulate gene expression in mammalian cells.
  • These repressors showed reduced dependence on guide RNA sequences and improved performance compared to existing CRISPRi platforms.
  • The study identified 100 bipartite and tripartite fusion proteins that can be used as CRISPRi effectors, with one particular platform, dCas9-ZIM3(KRAB)-MeCP2(t), showing improved gene repression of endogenous targets.
  • The research highlights the potential of combining novel repressor domains with strong KRAB repressors to enhance the reproducibility and utility of CRISPRi in mammalian cells.
  • Authors of the study include Andrew Kristof, Krithika Karunakaran, Christopher Allen, Paula Mizote, Sophie Briggs, Zixin Jian, Patrick Nash, and John Blazeck from the School of Chemical and Biomolecular Engineering at the Georgia Institute of Technology.
  • The research has implications for the development of more efficient and reliable CRISPRi platforms for gene regulation in various applications.

Statistics:

  • 100 bipartite and tripartite fusion proteins were screened for their ability to reduce gene expression as CRISPRi effectors.
  • 1 particularly effective CRISPRi platform, dCas9-ZIM3(KRAB)-MeCP2(t), was identified, showing improved gene repression of endogenous targets across several cell lines.
  • Genome-wide screens were used to evaluate the performance of the dCas9-ZIM3(KRAB)-MeCP2(t) platform, with improved gene repression observed at the transcript and protein level.

Sources:

  • Engineering novel CRISPRi repressors for highly efficient mammalian gene regulation. Genome Biology, 2025, 26(1):1-30.
  • NewsRx. Research on Genome Biology Published by Researchers at Georgia Institute of Technology (Engineering novel CRISPRi repressors for highly efficient mammalian gene regulation). Life Science Weekly. July 1, 2025; p 3160.